News
Market and company headlines
GEHCAll
Loading
09:00Oct 231 Story
09:00-17:00Oct 222 Stories
GE HealthCare Technologies (GEHC) vs. DHR and MDT: Can a $23.9B Backlog and AI Innovation Drive a Healthcare Re-Rating?
Is GEHC a good stock to buy? We came across a bullish thesis on GE HealthCare Technologies Inc. on Astute Optics – US’s Substack. The thesis was published on September 13th, when the stock was trading at $64.25, and GEHC gained 9.30% since then. The gain appears to reflect improving sentiment toward healthcare stocks and continued confidence […]
GEHC Expands Theranostics Imaging With 5 Global Collaborations
GE HealthCare expands its theranostics imaging push with five global collaborations to evaluate StarGuide GX, targeting advances in precision oncology and nuclear medicine.
05:00-10:00Oct 212 Stories
Here's What to Expect From GE HealthCare’s Next Earnings Report
GE HealthCare is scheduled to report its third-quarter results later this month, with analysts expecting double-digit earnings growth.
Body Composition Analyzers Market Size and Global Forecast to 2031 | Obesity and Preventive Care Fuel Demand for Body Composition Analyzers
The global body composition analyzers market is projected to grow from $0.99 billion in 2026 to $1.39 billion by 2031, a new report finds, with bioimpedance devices growing fastest; GE HealthCare, Omron, InBody and Tanita are among the companies profiled.Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Body Composition Analyzers Market: Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering. Hospitals & clinics, fitness & wellness centers, academic & research centers, and home us
09:00-13:00Oct 202 Stories
GE HealthCare announces five new global collaborations to advance the next generation of theranostics imaging
CHICAGO & VIENNA, October 20, 2026--GE HealthCare (Nasdaq: GEHC) today announced a global clinical evaluation program spanning three continents and five internationally recognized institutions to assess StarGuide™ GX,i its next-generation digital 4D SPECT/CT system. Participating institutions include Hadassah Medical Center in Israel; Mayo Clinic in the United States; Oncopole Claudius Regaud – Institut Universitaire du Cancer de Toulouse in France; Peking University First Hospital in China; and
GE HealthCare Wins Approval for MINItrace Magni Cyclotron in Europe
GE HealthCare secures CE Mark certification for MINItrace Magni and expands Copper-64 production capabilities, strengthening its PET imaging and theranostics portfolio.
09:00Oct 191 Story
08:00Oct 172 Stories
GE HealthCare Technologies (GEHC) Could Be 19% Undervalued As Imaging Push Gains Ground
GE HealthCare Technologies (GEHC) has put molecular imaging in focus after securing CE Mark approval for its MINItrace Magni cyclotron and widening PETtrace Solid Target capabilities to include Copper-64 production. GE HealthCare Technologies has seen mixed momentum around these updates, with the 7-day share price return up 5.83% and the 30-day move up 9.58%, yet the year-to-date share price still down 16.00% and the 1-year total shareholder return lower by 5.87%, even as product launches...
3 Stocks Delivering Bigger Dividends Despite Market Uncertainty
T-Mobile, GE HealthCare, and Danaos all recently raised dividends with low payout ratios, including T-Mobile's near-15% hike after SpaceX's spectrum deal hit its stock.
00:00-02:00Oct 172 Stories
Did Cyclotron CE Mark Just Shift GE HealthCare's (GEHC) Investment Narrative?
GE HealthCare Technologies recently expanded its PETtrace Solid Target Platform to support Copper-64 production and secured CE Mark approval for its MINItrace Magni cyclotron, increasing its role in PET radioisotope supply and theranostics research infrastructure. This combination of expanded isotope support and certified in house cyclotron production points to GE HealthCare’s push for deeper integration across molecular imaging hardware, radiopharmacy workflow, and emerging...
GE HealthCare (GEHC) Stock May Be Undervalued Despite The $945 Million Deal
GE HealthCare Technologies has climbed back in recent weeks after a weak run earlier in the year, which puts fresh focus on whether its current share price lines up with the earnings power backing it. With the stock closing at US$69.57, the key issue for you is how much of the business’s profit story is already reflected in that tag. The share price is still down 16.0% year to date, which makes the recent rebound an open question about whether the market is reassessing the earnings outlook...
12:00Oct 161 Story
08:00Oct 152 Stories
HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients
SANTA CLARA, Calif., October 15, 2026--HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome
GE HealthCare's MINItrace™ Magni achieves CE Mark; Copper-64 expands PETtrace™ Solid Target Platform beyond Gallium-68
CHICAGO, October 15, 2026--GE HealthCare (Nasdaq: GEHC) today announced that its MINItrace Magni cyclotron has achieved CE Mark and that its PETtrace Solid Target Platform is expanding beyond Gallium-68 with support for Copper-64 (⁶⁴Cu) production. Together, the developments reflect the company’s focus on helping institutions build the production capabilities behind their molecular imaging programs—from establishing local PET radioisotope production to supporting research into emerging radiophar
08:00Oct 141 Story
10:00Oct 131 Story
11:00Oct 91 Story
19:00Oct 61 Story
10:00Oct 51 Story
10:00Oct 21 Story
11:00-20:00Sep 302 Stories
This Healthcare Stock Just Raised Its Dividend by Nearly 15%.
GE HealthCare raised its quarterly dividend to $0.04 per share on Sept. 22 after Q2 revenue rose to $5.3 billion and adjusted earnings climbed to $1.13.
GE HealthCare (GEHC) Upgraded to Buy: Here's Why
GE HealthCare (GEHC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
13:00-16:00Sep 282 Stories
Healthcare Equipment and Supplies Stocks Q2 Highlights: GE HealthCare (NASDAQ:GEHC)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at GE HealthCare (NASDAQ:GEHC) and the best and worst performers in the healthcare equipment and supplies industry.
Here's Why You Should Add GEHC Stock to Your Portfolio Right Now
GEHC's record backlog, strong orders and AI-enabled innovations offer growth potential, while inflation and China remain key risks.
16:00Sep 231 Story
16:00-18:00Sep 222 Stories
GE HealthCare announces cash dividend increase for third quarter of 2026
CHICAGO, September 22, 2026--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.04 per share of Common Stock for the third quarter of 2026, an increase of 14% from the previous quarter. The dividend will be payable on November 13, 2026, to all shareholders of record as of October 23, 2026.
GE HealthCare appoints veteran finance executive Pascal Desroches to Board of Directors
CHICAGO, September 22, 2026--GE HealthCare (Nasdaq: GEHC) today announced the appointment of Pascal Desroches, Senior Executive Vice President and Chief Financial Officer (CFO) of AT&T (NYSE: T), a Fortune 50 company, to its Board of Directors, effective January 4, 2027. Mr. Desroches brings more than 30 years of leadership experience across finance, governance, and large-scale technology and digital transformation.
04:00-15:00Sep 222 Stories
GEHC Could Be Set For A Turnaround — Needham Sees 44% Upside For GE Healthcare After Nearly 21% YTD Slide
Needham initiated coverage with a ‘Buy’ rating and $93 price target, putting GEHC among the stocks it expects to outperform.
This SanDisk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Analysts initiated coverage: Buy ratings for RSI ($34), GEHC ($93), SNDK ($2,400), WPC ($73); Nike (NKE) rated Hold.
03:00Sep 221 Story
07:00-20:00Sep 212 Stories
Is GE HealthCare Technologies (GEHC) Undervalued On Its CareIntellect AI Launch?
GE HealthCare Technologies (GEHC) just launched CareIntellect for Operations, an AI SaaS tool that forecasts hospital capacity constraints up to 72 hours ahead and suggests actions, giving investors another data point on its software push. Despite the AI push, GE HealthCare Technologies shares have been under pressure, with the 30-day share price return down 13.38% and the year-to-date share price return down 21.75%, while the 1-year total shareholder return has declined 13.16% and the 3-year...
3 Profitable Stocks We Approach with Caution
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
01:00-09:00Sep 172 Stories
1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 Facing Headwinds
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
BTIG Reiterates Buy on GE HealthCare Techs, Maintains $79 Price Target
BTIG analyst Ryan Zimmerman reiterates GE HealthCare Techs (NASDAQ:GEHC) with a Buy and maintains $79 price target.
00:00Sep 171 Story
10:00-12:00Sep 162 Stories
GEHC or SYK: Which Is the Better Value Stock Right Now?
GEHC vs. SYK: Which Stock Is the Better Value Option?
GEHC Launches CareIntellect AI Tool to Optimize Hospital Operations
GE HealthCare launches an AI-powered SaaS tool that predicts hospital capacity challenges up to 72 hours ahead and recommends actions to ease bottlenecks.
08:00Sep 151 Story
11:00-23:00Sep 132 Stories
'GE HealthCare In Talks Over $1bn Deal For Maker of Cancer Scan Chemicals' - FT
https://www.ft.com/content/21b663e4-60ee-4937-a561-5b0f505676a2?syn-25a6b1a6=1
GE Healthcare in Talks To Acquire Sofie Biosciences, Maker of Cancer Scan Chemicals
GE Healthcare Technologies is considering making its second-biggest acquisition as its stock continues its downward spiral.
04:00Sep 31 Story
04:00-23:00Sep 22 Stories
GE HealthCare (GEHC) Stock Looks Reasonable On Earnings Yet Weak On Market Read
GE HealthCare Technologies has slipped year to date, yet on broad valuation checks the stock still screens as relatively cheap compared with its fundamentals. Investors are weighing that disconnect against a steady stream of product developments in imaging and cardiology. Year to date, GE HealthCare Technologies is down 14.8%, which may make the current share price more interesting for value focused investors who already follow the company. Progress in advanced imaging such as the Photonova...
GE HealthCare’s (GEHC) Latest Scanner Breakthrough Meets A Mixed Market
On August 31, GE HealthCare (NASDAQ:GEHC) announced that its Photonova Spectra photon-counting CT scanner had received CE Mark approval, opening the door to sales across Europe and other regions that recognize the certification. The clearance followed US FDA 510(k) clearance and Japanese regulatory approval in March 2026, meaning the machine cleared three major regulatory bodies […]
07:00Sep 11 Story
11:00-13:00Aug 312 Stories
GEHC vs. HAE: Which Stock Is the Better Value Option?
GEHC vs. HAE: Which Stock Is the Better Value Option?
GE HealthCare Unveils Next-Gen Vivid Cardiac Ultrasound Systems
GEHC expands its Vivid cardiovascular ultrasound portfolio with three systems featuring AI tools and cSound imaging for varied care settings.
09:00Aug 311 Story
07:00-13:00Aug 212 Stories
FDA Announces GE Healthcare Issues Early Alert For Portrait Core Services Software Issue
https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-portrait-core-services-software-issue-ge-healthcare
3 Cash-Producing Stocks with Open Questions
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
05:00Aug 211 Story
10:00Aug 201 Story
04:00-08:00Aug 192 Stories
GE HealthCare names new CFO
William Grogan will take over the chief finance job vacated by Jay Saccaro. Stifel analysts called Grogan’s “no-nonsense” mindset on setting expectations a strength.
BTIG Reiterates Buy on GE HealthCare Techs, Maintains $79 Price Target
BTIG analyst Ryan Zimmerman reiterates GE HealthCare Techs (NASDAQ:GEHC) with a Buy and maintains $79 price target.
10:00-15:00Aug 182 Stories
Sector Update: Healthcare Stocks Rise Tuesday Afternoon
Healthcare stocks were higher Tuesday afternoon, with the NYSE Healthcare Index rising 1.8% and the
GE HealthCare appoints William Grogan as Chief Financial Officer
CHICAGO, August 18, 2026--GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, today announced the appointment of William (Bill) Grogan as Chief Financial Officer, effective September 14, 2026. Grogan succeeds Jay Saccaro, who, as previously announced, stepped down for an expanded role outside of the medical technology industry. George Newcomb, who is serving as interim Chief Financial Officer, will continue in his role as Controller and Chief Accounting Officer.